Is plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) determination in donors and recipients predictive of renal function after kidney transplantation?

Clinical Biochemistry

Volumn 47, Issue 15, 2014, Pages 68-72

  Buemi, Antoine ^a   Musuamba, Flora ^a   Frederic, Stephan ^a   Douhet, Anne ^a   De Meyer, Martine ^a   De Pauw, Luc ^a   Darius, Tom ^a   Kanaan, Nada ^a   Wallemacq, Pierre ^a   Mourad, Michel ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Kidney transplant; NGAL; Renal function

Indexed keywords

BASILIXIMAB; BIOLOGICAL MARKER; CREATININE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TACROLIMUS; ACUTE PHASE PROTEIN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CLINICAL PRACTICE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DELAYED GRAFT FUNCTION; FEMALE; GLOMERULUS FILTRATION; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HUMAN; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVING DONOR; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; BLOOD; DONOR; GLOMERULUS FILTRATION RATE; KIDNEY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; URINE;

ACUTE-PHASE PROTEINS; ADULT; AGED; CREATININE; DELAYED GRAFT FUNCTION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; LIPOCALINS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; TISSUE DONORS; TRANSPLANT RECIPIENTS;

EID: 84910032592     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.06.079     Document Type: Article

References (26)

1. Ojo A.O., Wolfe R.A., Held P.J., Port F.K., Schmouder R.L. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997, 63:968-974.
2. Irish W.D., McCollum D.A., Tesi R.J., Owen A.B., Brennan D.C., Bailly J.E., et al. Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol 2003, 14:2967-2974.
3. Perico N., Cattaneo D., Sayegh M.H., Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004, 364:1814-1827.
4. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth T. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999, 130:461-470.
5. Shlipak M.G., Matsushita K., Ärnlöf J., Inker L.A., Katz R., Polkinghorne K.R., et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 2013, 369:932-943.
6. Flower D.R. The lipocalin protein family: structure and function. Biochem J 1996, 318:1-14.
7. Mishra J., Dent C., Tarabishi R., Mitsnefes M.M., Ma Q., Kelly C., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005, 365:1231-1238.
8. Jochmans I., Lerut E., van Pelt J., Monbaliu, Pirenne J. Circulating AST, H-FABP and NGAL are early and accurate biomarkers of graft injury and dysfunction in a preclinical model of kidney transplantation. Ann Surg 2011, 254:784-791.
9. Haase M., Bellomo R., Devarajan P., Schlattmann P., Haase-Fielitz A. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009, 54:1012-1024.
10. Cruz D.N., de Cal M., Garzotto F., Perazella M.A., Lentini P., Corradi V., et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med 2010, 36:444-451.
11. Hu C., Sale M.E. A joint model for nonlinear longitudinal data with informative dropout. J Pharmacokinet Pharmacodyn 2003, 30:83-103.
12. Opelz G., Wujciak T., Döhler B., Scherer S., Mytilineos J. HLA compatibility and organ transplant survival. Collaborative transplant study. Rev Immunogenet 1999, 1:334-342.
13. Cecka J.M. The UNOS scientific renal transplant registry. Clin Transpl 2001, 1-18.
14. Skrabal C.A., Thompson L.O., Potapov E.V., Southard R.E., Joyce D.L., Youker K.A., et al. Organ-specific regulation of pro-inflammatory molecules in heart, lung, and kidney following brain death. J Surg Res 2005, 123:118-125.
15. Stangl M., Zerkaulen T., Theodorakis J., Illner W., Schneeberger H., Land W., et al. Influence of brain death on cytokine release in organ donors and renal transplants. Transplant Proc 2001, 33:1284-1285.
16. Parikh C.R., Jani A., Mishra J., Ma Q., Kelly C., Barasch J., et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006, 6:1639-1645.
17. Hall I.E., Yarlagadda S.G., Coca S.G., Wang Z., Doshi M., Devarajan P., et al. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol 2010, 21:189-197.
18. Fonseca I., Oliveira J.C., Almeida M., Cruz M., Malho A., Martins L.S., et al. Neutrophil gelatinase-associated lipocalin in kidney transplantation is an early marker of graft dysfunction and is associated with one-year renal function. J Transplant 2013, 1-12.
19. Bataille A., Abbas S., Semoun O., Bourgeois E., Marie O., Bonnet F., et al. Plasma neutrophil gelatinase-associated lipocalin in kidney transplantation and early renal function prediction. Transplantation 2011, 92:1024-1030.
20. Hollmen M.E., Kyllönen L.E., Inkinen K.A., Lalla M.L., Merenmies J., Salmela K.T. Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study. Crit Care 2011, 15:R121.
21. Rostami Z., Nikpoor M., Einollahi B. Urinary neutrophil gelatinase-associated lipocalin (NGAL) for early diagnosis of acute kidney injury in renal transplant recipients. Nephrourol Mon 2013, 5:745-752.
22. Kaufeld J.K., Gwinner W., Scheffner I., Haller H.G., Schiffer M. Urinary NGAL ratio is not a sensitive biomarker for monitoring acute tubular injury in kidney transplant patients: NGAL and ATI in renal transplant patients. J Transplant 2012, 1-8.
23. Lebkowska U., Malyszko J., Lebkowska A., Koc-Zorawska E., Lebkowski W., Malyszko J.S., et al. Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study. Transplant Proc 2009, 41:154-157.
24. Mishra J., Ma Q., Kelly C., Mitsnefes M., Mori K., Barasch J., et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol 2006, 21:856-863.
25. Kohei J., Ishida H., Kazunary T., Tsuchiya K., Nitta K. Neutrophil gelatinase-associated lipocalin is a sensitive biomarker for the early diagnosis of acute rejection after living-donor kidney transplantation. Int Urol Nephrol 2013, 45:1159-1167.
26. Bolignano D., Donato V., Coppolino G., Campo S., Buemi A., Lacquaniti A., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis 2008, 52:595-605.